Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
Upstream Bio Series A round, June 2022
Upstream Bio raised a Series A round for 200,000,000 USD in June, 2022.
Overview
Structured Data
Issues
Contributors
Activity
All edits
Edits on 20 Jan, 2023
Semyon Kolychev
edited on 20 Jan, 2023
Edits made to:
Infobox
(
+1
properties)
Infobox
Funded Company
Upstream Bio
0
Funding Round Date
June 2, 2022
0
Funding Round Amount (USD)
200,000,000
0
Funding Type
Series A
0
Investment
OrbiMed
0
Decheng Capital
0
Omega Funds
0
HBM Healthcare Investments AG
0
Access Biotechnology
0
Samsara BioCapital
0
Date Announced
June 2, 2022
0
Edits on 13 Jun, 2022
Semyon Kolychev
edited on 13 Jun, 2022
Edits made to:
Infobox
(
+6
properties)
Infobox
Investment
OrbiMed
Decheng Capital
Omega Funds
HBM Healthcare Investments AG
Access Biotechnology
Samsara BioCapital
Edits on 4 Jun, 2022
"Created via: Entity Importer"
Golden AI
created this topic on 4 Jun, 2022
Edits made to:
Infobox
(
+6
properties)
Upstream Bio Series A round, June 2022
Infobox
Is a
Funding round
Funding type
Series A
Funded company
Upstream Bio
Funding round amount (USD)
200,000,000
Announcement URL
https://www.benzinga.com/pressreleases/22/06/b27516807/upstream-bio-launches-with-200m-series-a-financing-to-advance-novel-therapeutics-for-allergic-and-
Funding round date
June 2, 2022
Find more entities like Upstream Bio Series A round, June 2022
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE